Litcius/Paper detail

Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis

Daniele Marinelli, A. Nuccio, Alessandro Di Federico, Francesca Ambrosi, Pietro Bertoglio, Eleonora Faccioli, Roberto Ferrara, Alessandra Ferro, Raffaele Giusti, Francesco Guerrera, Marco Mammana, Alessandra Pittaro, Matteo Sepulcri, Giuseppe Viscardi, Filippo Tommaso Gallina

2024Journal of Thoracic Oncology29 citationsDOI

Topics & Concepts

ChemoimmunotherapyMedicineMeta-analysisOncologyAdjuvantInternal medicineNeoadjuvant therapyComplete responseChemotherapyCancerCyclophosphamideBreast cancerColorectal and Anal CarcinomasLung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis | Litcius